- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Comdisco lands $25 million lease
The U.K. affiliate of medicalequipment lessor Comdisco Medical Equipment Group has inked adeal to supply a Scottish hospital with $25 million in high-technologymedical equipment. Comdisco said the deal is believed to be oneof the largest leases of
The U.K. affiliate of medicalequipment lessor Comdisco Medical Equipment Group has inked adeal to supply a Scottish hospital with $25 million in high-technologymedical equipment. Comdisco said the deal is believed to be oneof the largest leases of high-tech equipment to a health-careprovider in the world.
Comdisco U.K. signed the deal with Health Care International,which has built a 260-bed tertiary care hospital near Glasgow,Scotland. The technology under lease includes medical imagingequipment, computers, telecommunications equipment and cardiacmonitoring devices.
The lease highlights Comdisco's increased focus on the internationalmarket, according to the company. Another sign of that focus camethis month, when Comdisco shipped a refurbished cardiac catheterizationlab to a Moscow hospital. The unit is one of only six in Russiaand the second supplied by Comdisco, according to the company.Comdisco supplied the first lab last year to a medical facilityin central Siberia.
New Study Assesses Long-Term Outcomes of PSMA PET Use in PCa Recurrence Cases
October 24th 2024For patients with biochemical recurrence of prostate cancer, PSMA PET imaging may facilitate a 12.8 percent lower incidence of prostate cancer mortality in contrast to the combination of CT and bone scan, according to long-term outcome estimates from a new decision-analytic modeling study.
Can Diffusion MRI Predict Patient Response to Neoadjuvant Chemotherapy for Breast Cancer?
October 23rd 2024A model emphasizing time-dependent diffusion MRI was 15 percent more effective than apparent diffusion coefficient (ADC) measurements at predicting pathologic complete response to neoadjuvant chemotherapy for women with breast cancer, according to new research.
